Transcatheter Left Atrial Appendage Occlusion: First Case of Nepal
Open Access
- 30 October 2025
- journal article
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 22 (2) , 71-74
Abstract
Transcatheter left atrial appendage occlusion (LAAO) is a valuable therapeutic option for stroke prevention in patients with non-valvular atrial fibrillation at high bleeding risk. Worldwide acceptance of LAAO therapy as an alternative to oral anticoagulation is growing. The most recent 2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion suggests Oral anticoagulation (OAC) or LAAO as treatment options for stroke prevention. While most patients are offered stroke prevention with OAC, those with elevated bleeding risk, prior bleeding complications, or strong preferences to avoid long-term anticoagulation would reasonably choose LAAO over OAC. In this case report we describe the first successful transcatheter LAAO in Nepal in a 75 years old male with CHA2DS2-VASc of 3 and HAS-BLED score of 3. Though he was treated with oral anticoagulation to prevent stroke but due to hemoptysis he could not continue it.TO prevent stroke patient party opted for the LAAO procedure. Under general anesthesia with Transesophageal echocardiogram guidance, patient underwent successful transcatheter LAAO with 31 mm Amulet device. He was discharged the next day of the procedure in stable condition without any complication.Keywords
This publication has 14 references indexed in Scilit:
- 2025 SCAI/HRS clinical practice guidelines on transcatheter left atrial appendage occlusionHeart Rhythm, 2025
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2024
- A giant left atrial appendage: a case report on the feasibility of closure with a custom-made deviceEuropean Heart Journal - Case Reports, 2023
- Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020Journal of the American Heart Association, 2022
- Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationJACC, 2020
- Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial FibrillationJAMA, 2014
- Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin TherapyJACC, 2014
- Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAmerican Heart Journal, 2014
- Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial FibrillationCirculation, 2013
- Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillationInternational Journal of Cardiology, 1997